Psychiatry and Neurology, Neurology · Eatontown, NJ
NPI
1952411340
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
135 Highway 35
Eatontown, NJ, 07724
Phone (732) 798-3620
Groups this clinician bills Medicare through
Medicare paid, 2024
$15K
201 services
Medicare patients, 2024
94
Average age 66
Drug cost, 2024
$2.1M
926 prescriptions
Company payments, 2025
$46K
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Amos Katz was code 99214 (office e&m - established), 194 times for 93 patients. In total Amos Katz billed 201 services in 3 codes, and Medicare paid $15K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-03-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 194 | 93 | $73.14 | $14K |
By year: 2022 $28K for 394 services; 2023 $17K for 236 services; 2024 $15K for 201 services.
Medicare prescription drug claims, 2024
In 2024, the drug Amos Katz prescribed most often to Medicare patients was Baclofen, with 124 prescriptions and refills. In total Amos Katz wrote 926 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Baclofen Generic | 124 | 266 | 49 | $3,003 |
| Gabapentin Generic | 47 | 116 | 25 | $1,176 |
| Mayzent Siponimod | 44 | 48 | Under 11 | $471K |
| Dalfampridine Er Dalfampridine | 41 | 81 | 15 | $15K |
| Escitalopram Oxalate Generic | 40 | 112 | 15 | $535 |
| Modafinil Generic | 39 | 46 | 14 | $3,396 |
| Zeposia Ozanimod Hydrochloride | 35 | 49 | Under 11 | $432K |
| Alprazolam Generic | 32 | 33 | 11 | $180 |
| Tizanidine Hcl Generic | 29 | 48 | Under 11 | $544 |
| Teriflunomide Generic | 29 | 45 | Under 11 | $114K |
| Duloxetine Hcl Generic | 24 | 64 | Under 11 | $582 |
| Aubagio Teriflunomide | 23 | 27 | Under 11 | $251K |
| Sertraline Hcl Generic | 23 | 52 | Under 11 | $188 |
| Vumerity Diroximel Fumarate | 21 | 21 | Under 11 | $200K |
| Clonazepam Generic | 20 | 22 | Under 11 | $95.22 |
Brand drugs: 184 claims; generic drugs: 742 claims; opioid claims: 33.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Amos Katz $46K ($46K in general payments such as food, travel and fees) from 18 companies. The largest payer was TG Therapeutics, Inc. with $30K.
| Company | Payments | Amount |
|---|---|---|
| TG Therapeutics, Inc. TGTX | 29 | $30K |
| Biogen, Inc. BIIB | 16 | $7,894 |
| Genentech USA, Inc. ROG.SW | 12 | $4,537 |
| E.R. Squibb & Sons, L.L.C. BMY | 4 | $2,833 |
| EMD Serono, Inc. MRK.DE | 13 | $288 |
| Abbvie Inc. ABBV | 4 | $68.49 |
| Celgene Corporation BMY | 4 | $61.01 |
| Insulet Corporation PODD | 2 | $53.68 |
| Vanda Pharmaceuticals Inc. VNDA | 3 | $48.11 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $36.31 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.